Amy Sullivan Io Biotech, Inc. (IOBT) insider trading activity

IOBT Quotes by TradingView

Amy Sullivan is Chief Financial Officer of IO Biotech, Inc.. Currently has a direct ownership of 84,632 shares of IOBT, which is worth approximately $77,861. The most recent transaction as insider was on Dec 23, 2024, when has been sold 10,250 shares (Common Stock) at a price of $0.83 per share, resulting in proceeds of $8,507. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.6K
13.78% 3M change
13.78% 12M change
Total Value Held $77,861

Amy Sullivan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2024
BUY
Open market or private purchase
$8,507 $0.83 p/Share
10,250 Added 10.8%
84,632 Common Stock
Aug 09 2023
BUY
Grant, award, or other acquisition
$93,825 $1.9 p/Share
49,382 Added 39.9%
74,382 Common Stock
Mar 17 2023
BUY
Open market or private purchase
$57,999 $2.32 p/Share
25,000 Added 50.0%
25,000 Common Stock
AS

Amy Sullivan

Chief Financial Officer
Copenhagen, G7

Track Institutional and Insider Activities on IOBT

Follow IO Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOBT shares.

Notify only if

Insider Trading

Get notified when an Io Biotech, Inc. insider buys or sells IOBT shares.

Notify only if

News

Receive news related to IO Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IOBT